We consider resequencing studies of associated loci and the problem of prioritizing sequence variants for functional follow-up. Working within the multivariate linear regression framework helps us to account for correlation across variants, and adopting a Bayesian approach naturally leads to posterior probabilities that incorporate all information about the variants' function. We describe two novel prior distributions that facilitate learning the role of each variant by borrowing evidence across phenotypes and across mutations in the same gene. We illustrate their potential advantages with simulations and re-analyzing a dataset of sequencing variants.
Introduction
Genome-Wide Association Studies (GWAS) have allowed human geneticists to compile a rather long list of loci where DNA variation appears to be reproducibly associated to phenotypic variability (NHGRI 2015) . While these might represent only a subset of the portion of the genome that is important for the traits under study (Manolio et al. 2009) , there is little doubt that understanding the characteristics and mechanisms of functional variants at these loci is a necessary next step. As resequencing becomes ever more affordable, follow-up investigations of GWAS loci often start with a comprehensive catalogue of their genetic variants in a sample of thousands of individuals, raising the question of how to sort through these results.
Among the many challenges, let us discuss two: multiple common variants are often in high linkage disequilibrium, making it difficult to distinguish their roles; and rare variants are present in a small enough portion of the sample that statistical statements become impossible. With this in mind, it has been noted that (a) it is important to account for correlation between variables to obtain useful ranking; (b) we should increasingly be able to take advantage of the information gathered through other studies; and (c) Bayesian models provide a principled approach to guide variable prioritization. To adequately select among variables in the same locus, researchers have resorted to model selection approaches (Valdar et al. 2012) or approximations of the joint distribution of univariate test statistics (Faye et al. 2013; . Prior information on variant annotation has been incorporated in models for eQTL (Veyrieras et al. 2008 ) and more recently for general traits (Pickrell 2014; Kichaev et al. 2014; Chung et al. 2014) , and annotation programs increasingly attempt to include information on identified genetic loci (Wang et al. 2010) . Prioritization often relies on Bayes's theorem, and Bayesian methods have received renewed attention in the context of GWAS data analysis (Guan and Stephens 2011; Peltola et al. 2012a,b) , genomic prediction (Gianola 2013) , and the evaluation of heritability (Zhou et al. 2013) .
In this context, we explore the advantages of careful specification of the prior distributions on variants. We are motivated by the analysis of an exome resequencing study where individual level data is available for a set of GWAS loci associated with lipid traits, and variants do not differ significantly in terms of annotation. The structure of this dataset informs some of our modeling choices, but the characteristics of the prior distributions that we describe have more general implications. We show how one can capitalize on hierarchical prior distributions to learn about the functionality of a variant by (i) looking across multiple phenotypes and (ii) aggregating the effects of multiple rare variants at the same locus. Since the power of Bayesian methods in borrowing information is well known, it is not surprising that others have explored their application in this context. For example, Yi et al. (2011) illustrate the use of priors to model a group effect for multiple rare variants, while Stephens (2013) describes models for the analysis of multiple traits. Our approach, however, is distinct from others in that it strives to achieve all of the following: (1) providing variant-specific inference-while linking information across traits and sites; (2) constructing a multivariate model that incorporates the contributions of all relevant sites; and (3) accounting for the large number of variants tested, effectively enacting a form of multiple comparison adjustment.
This paper is organized as follows. We devote Section 2 to the description of the model and different prior choices, using an approximation of the posterior distribution to illustrate their implications for inference. Section 3 describes the MCMC scheme used to sample the posterior, the setting used for simulations, and the criteria for comparison of methods. Section 4 presents the results of simulation studies highlighting the potential of our proposal, as well as the description of the analysis of the motivating dataset.
Prior distributions on genetic variants
Throughout this work, we will model the expected value of the trait y in subject i as a linear function of the individual genotypes at a set T of variants x T : E(y i ) = x T i β T . While this is a fairly strong assumption, it is rather common in both genetics and statistics. Certainly, it becomes more realistic once we postulate that the effect of other known covariates is properly regressed out and also stipulate that the genetic regions under study have been implicated in prior GWAS, which, by design, tend to identify loci acting additively and independently. For definiteness, we represent genotypes with minor allele counts (standardized to have mean zero and variance one), but dominant effects can be incorporated as well. We postulate that the error terms are iid Gaussian N (0, 1/ρ), which by and large is a convenient assumption that can be partially relaxed at the price of computational costs.
While the set T contains only allele counts at important variants, the researcher typically does not know their identity, but rather has genotypic information on a collection of p sites that are assumed to include all the important ones. This last assumption is strong and should be relaxed to consider the situation where some relevant genetic variants are not included in the typed sites. Fortunately, this can often be achieved by including random effects in the model-a generalization that we do not directly consider here but that does not pose substantial challenges. In this work, the main task of the researcher is to discover which variants belong to the set T . It is certainly possible to imagine other goals (such as constructing a model with maximal predictive power for y), but our task here is classical fine mapping: identifying the variants that have 'causal' effect. We put causal in quotation marks as it is an unfortunately charged term; we use it to indicate a variable that belongs to the model E(y i ) = x T i β T . Let y be the vector of trait values across n subjects, and let X be the matrix collecting by rows the genotypes of each subject at all typed variants. Then, we write E(y) = Xβ, where it is to be understood that any coefficient β v corresponding to a variant v not in T is equal to zero. To facilitate presentation and simulations, we take p < n; this assumption is realistic in the context of our goal of fine mapping, and can eventually be relaxed.
With this notation, the parameters of the model are the precision ρ and the vector of coefficients β. We now describe their prior distributions. Following standard practice, we take ρ ∼ Gamma(α ρ , λ ρ ). (See Guan and Stephens (2011) for another approach, specifically targeting GWAS and relying on heritability information.) On the vector β, we want a prior that reflects our model selection goals and our understanding of the genetic architecture. There are several aspects to consider: (a) we believe that only some of the typed variants have an effect on the trait; (b) given the exhaustive nature of the genotyping process, we believe that most of the variants available do not directly influence the trait; (c) it seems reasonable that genetic variation that has an effect on one trait (so that it is definitely not neutral) might also influence other traits; and finally (d) it appears likely that if a rare variant influences the outcome, other nearby rare variants might also be nonneutral. Our main goal is to describe prior distributions on β that incorporate these beliefs. We start by recalling one class of priors that reflect (a) and (b) and then move on to generalizations that account for the sharing of information implied by (c) and (d).
Priors for variable selection
A classic prior choice for model selection (George and McCulloch 1993 ) is most easily described using a vector of indicator variables Z such that Z v = 0 =⇒ β v = 0. All the prior distributions we will consider have the feature of giving positive probability to configurations of β with a number of coordinates equal to 0. The Z v are assumed iid Bernoulli with parameter ω that governs the sparsity of the model and has a Beta(A ω , B ω ) prior. Let β Z indicate the collection of elements of β corresponding to nonzero elements of Z, and let X Z be the corresponding columns of X. It has been found useful to assume (β Z |Z, ρ, τ) ∼ N 0, τ 2 ρ Σ Z , where τ ∼ Unif(τ 1 , τ 2 ) links the error variance to the size of the β coefficients, and the known matrix Σ Z is taken to have one of two forms: I |Z| (the identity matrix of size |Z|, where |Z| indicates the number of nonzero components of the vector Z) or n(X T Z X Z ) −1 , which is referred to as the g-prior (Zellner 1986 ). Various views on the choice of Σ Z have been put forth (Chipman et al. 2001; Heaton and Scott 2010; Guan and Stephens 2011) , but the strongest argument for the g-prior is that it provides computational benefits. For either choice of Σ Z , all of its diagonal entries are equal, resulting in an equal prior variance for each of the β v . Working with standardized regressors implies that the original effect sizes are expected to be larger for rare variants than for common variants-which is in agreement with evolutionary theory.
One of the advantages of the priors specified in the previous paragraph is that it is possible to integrate ω, β, and ρ out of the posterior distribution. This allows us to obtain samples from the posterior with a collapsed Gibbs sampler, which not only reduces the computation at each iteration but also improves its convergence rate (Liu 1994) . The prior densities for τ and Z will be denoted, respectively, f τ (τ) and f Z (Z)-the latter being easily obtained from the betabinomial distribution assumed for |Z|. Integrating β and ρ out is lengthy but straightforward (see supplementary material) and gives the marginal posterior density
where
Choosing Σ Z as in the g-prior leads to a simplification of the last factor, thereby avoiding the evaluation of one determinant at each iteration.
In the following, Z [−v] denotes the subvector of Z obtained by removing Z v . Along the lines of Malsiner-Walli and Wagner (2011), we present an approximation of the posterior expected value E[Z v |Z [−v] , τ, y], which-while derived under somewhat restrictive assumptionsillustrates the role of various elements of the prior in the final inferential result. Consider the case when the columns of X are orthogonal, which implies X T X ≈ nI p and the two choices of Σ Z are essentially the same. Furthermore, x v , y = x v , Xβ + ≈ nβ v + x v , , with the last term distributed as N (0, n ρ (Z v nτ 2 + 1)); in this context, distinguishing signal from noise requires nτ 2 1, so we assume this to be the case. We also assume that the portion of variance explained by the model is small, as is typically the case for genetic association. If one further chooses
where η v = x T v y/ ny T y is approximately the correlation between variant v and the trait (see supplementary material for a detailed derivation). From (2), one gathers that increasing |Z [−v] |, which is the number of variables already in the model, increases the chance of a new variable to enter (thanks to the fact that the overall sparsity parameter ω is learned). On the other hand, augmenting the total number of possible regressors p will make it harder for a variable to be selected-effectively adjusting for multiple hypothesis testing. Now that we have introduced this basic model selection framework, we can consider modifications that facilitate learning about the role of a variant across multiple traits and sites. We start with the first problem.
Learning across traits
Understanding which variants are 'causal' is not easy: many of the variants in one region are in linkage disequilibrium and distinguishing between them is sometimes challenging. To consider the variants' effects on multiple traits might be helpful. On the one hand, if a genetic variation is functional, it can be expected to impact more than one phenotype. On the other hand, even if random variation makes it hard to distinguish the predictive power of a causal variant from that of a non-causal neighboring variant for one phenotype, it is hard to imagine that random variation would make these indistinguishable for the prediction of multiple traits. With this in mind, let us generalize the variant selection problem described in the previous section to handle multiple traits.
Extending the notation, let y t be the standardized values for trait t, β t the coefficients of X in the mean E(y t ), and Z t the corresponding indicator vector. We organize these by column in a n × q matrix Y, a p × q matrix β, and a p × q matrix Z. Also, let s v = ∑ t Z vt denote the number of traits associated with variant v, let β Z t be the entries of β t corresponding to entries equal to one in Z t , and let X Z t be the corresponding columns of X. The data-generating model is y t = X Z t β Z t + t with t ∼ N 0, 1 ρ t I n , and the priors on ρ t are simple extensions of the one used previously: ρ t iid Gamma(α ρ , λ ρ ). We want a prior for β that keeps the model selection flavor but that allows learning about the role of a variant across traits. One possibility, first proposed by Jia and Xu (2007) , is to introduce a variant-specific probability of functional effect ν v , constant across traits and a priori independent with ν v ∼ Beta(A v , B v ), where A v and B v can capture annotation information. Following the setup of the previous section, we then take (Z vt |ν v ) independent Bernoulli(ν v ), set β vt = 0 whenever Z vt = 0, and let (β Z t |Z t , ρ t , τ) be independent across t with distribution N (0,
(Note that one could have a different τ t for each trait, but this appears less meaningful than having different ρ t that allow one to capture variation in heritability across traits.)
Across Traits b prior
. . .
Using the same assumptions as in the previous section, we can derive an approxi-
when the columns of X are orthogonal:
where h vt = In order to rescue this important feature of the basic prior, we introduce another layer in the hierarchical priors. Let W be a vector of indicator variables of length p: if
We can still integrate n, w W , b, and r out of the posterior to obtain f W,Z,t (W, Z, t|Y) similar to (1) except that the last two factors are replaced by a product of q such factors and f Z is replaced by
provided that
Figure 1: Schematic representation of the Across Traits prior distribution on β. Hyperparameters are indicated in blue. The red part describes all random objects and their dependency structure: unless explicitly indicated otherwise, random variables are independent. Boxes identify variables that share one of the distributions depicted in black.
Using the same assumptions as in the previous section, we can derive an approximation for
This highlights some consequences of the selected prior distribution: q has taken the role of p, and the role of each variant for each trait is judged not in reference to all the other variants, but only in comparison to the effect of the same variant across traits. In other words, there is no adjustment for the multiplicity of queried variants. Bottolo et al. (2011) previously observed that sparsity of Z t could not be controlled by specification of the priors in this approach, and proposed letting Z vt have Bernoulli parameter ν v ω t with independent priors on each factor. We propose a different remedy by introducing another layer in the hierarchical priors. Let W be a vector of indicator variables of length p:
, as before. This leads to the schematic in Figure 1 : ω W is now the sparsity parameter, which enables dynamic adjustment for multiplicity as it is learned; and the variation in ν v across v allows variation in the average number of impacted traits per locus: some variants can be highly pleiotropic, while others relevant for one trait only. Note that the introduction of W effectively specifies a hierarchical prior on ω W ; there are certainly many other such choices, but the one we adopt has some advantages in terms of interpretability, given the central role of the sparsity parameter ω W . Formally, we can still integrate ν, ω W , β, and ρ out of the posterior to obtain f W,Z,τ (W, Z, τ|Y) similar to (1) except that the last two factors are replaced by a product of q such factors and f Z is replaced by
, where Z v denotes row v of Z; Z [−v] denotes the sub-matrix of Z obtained by deleting row v; and
with the summation extending over all 2 q possible values of Z v . This still enables learning across phenotypes given that η vt for all t enter in the formula, but now ω W is learned across variants. As a consequence, the consideration of additional spurious covariates will decrease this expected value. These characteristics appear promising, so we adopt this as a prior and refer to approaches using it as learning Across Traits. We include the first proposal in some comparison studies, indicating it as the Unadjusted approach to emphasize the fact that it does not include an adjustment for multiplicity.
Learning across sites
We now consider another form of 'learning from the experience of others' to improve our ability to identify functional variants. We are particularly interested in rare variants, which might be observed in just a handful of individuals in a sample, thus making it very hard to evaluate their effect. It is reasonable to assume that if one rare variant in a gene has an impact on a trait, other rare variants in the same gene also might be functional. In other words, we would like to outline a hierarchical prior that allows us to 'borrow strength' among neighboring mutations. We define r groups of variants, and let γ(v) indicate the group to which variant v belongs. Let G = (G 1 , . . . , G r ) be a vector of indicator variables associated to the groups; we use these to link information coming from different variants. Specifically, if
) when the number p g of variants that belong to group g is greater than one, and ν g = 1 for groups with only one variant. The Z v are iid Bernoulli with parameter ν γ (v) . Close to what was considered earlier, (G g 
This results in the partially exchangeable prior on β represented in Figure 2 : variants in the same group share ν g , thereby sharing information on their functionality.
Let s g = ∑ γ(v)=g Z v denote the number of variants in group g that are associated with the trait. The marginal posterior distribution is as in (1) except that the prior f Z (Z) is replaced by the joint prior for Z and G, which is given by (3) with the appropriate changes: r in place of p, p g in place of q, and so forth. Group g partitions Z into Z g (the elements of Z in group g) and Z [−g] . In a manner similar to the preceding approximations,
This results in the partially exchangeable prior on b represented in Figure ? ?: variants in the same group share n g : information on their functionality can be shared across the different elements.
Across Sites b prior
Let p g be the number of variants that belong to group g, and let s g = Â g(v)=g Z v denote the number of variants in group g that are associated with the trait. The marginal posterior distribution is as in (1) except that the prior f Z (Z) is replaced by the joint prior for Z and G, which is given by (3) with the appropriate changes: r in place of p, p g in place of q, and so forth. Let Z g be the elements of Z in group g and Z [ g] be the rest. In a manner similar to the preceding approximations,
with the summation being over all 2 p g possible values of Z g . We refer to approaches that adopt this prior as learning Across Sites.
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Figure 2: Schematic representation of the Across Sites prior distribution on β. Hyperparameters are indicated in blue. The red part describes all random objects and their dependency structure: unless explicitly indicated otherwise, random variables are independent. Boxes identify variables that share one of the distributions depicted in black.
with the summation being over all 2 p g possible values of Z g . When group g contains only one variant v, the summation is replaced by (1
. We refer to approaches that adopt this prior as learning Across Sites.
Methods

MCMC sampling
MCMC sampling is used to generate samples of τ and all indicator variables. Since the posterior distribution for each of the models is only known up to a normalizing factor, we use the Metropolis-Hastings algorithm. For τ, following the common practice of using a truncated Gaussian for the proposal distribution works well. The discrete indicator variables pose a greater challenge, although integrating out β means that the sample space has a fixed dimension and eliminates the need for a reversible jump MCMC. When we have only one layer of indicator variables Z, we first choose randomly whether to add or remove a variant and then choose uniformly from the appropriate variants. If the prior distribution is described using higher level indicators as well, then proposed changes to both levels must be consistent: if an entry of W is changed from one to zero, the associated entries of Z also have to be zeroed; when proposing to change an entry of W from zero to one, we randomly draw the associated entries of Z. We also allow proposals in which W does not change; in this case, we randomly select one of its nonzero entries and draw a proposal for the associated entries of Z as in the proposals without W. Details of the algorithm are in the supplement. These simple proposal distributions will have trouble in two situations. The most common is when two or more variants are strongly associated with a phenotype but are also strongly correlated with each other due to LD. A chain of samples will tend to stick with one of the variants being in the model while the other correlated variants are left out. The other problematic situation is when the effects of two variants on a phenotype depend upon each other, so neither variant is likely to enter the model by itself but together they are causal. Others (Guan and Stephens 2011; Peltola et al. 2012a,b) have described proposal distributions that overcome these difficulties and that can be reasonably applied to our setting-even if we do not investigate this in detail as our focus is on the description of novel prior distributions.
The main instrument of inference for us is Z (the average of realized values of Z), which we use to select variables to be included in the various models. We therefore base our basic convergence checks on these. By default, in the R code distributed in the package ptycho we simply run four chains starting from different points, compute the averages for each chain separately, and then check the range ∆Z of these averages, requiring 95% of these values to be lower than a fixed value. Details on the MCMC can be found in the supplementary materials and the R package by Stell (2015) .
Evaluation of variable selection performance
To investigate the performance of the proposed priors, we apply them to simulated and real data. For trait t, we select the variants v with posterior average Z vt larger than a certain threshold ξ ∈ (0, 1): S t ≡ {v : Z vt > ξ}. For benchmarking purposes, we will also analyze the datasets with some non-Bayesian approaches. Specifically we will consider (a) the Lasso (Tibshirani 1996) ; (b) a set of univariate linear regressions (one for each trait and variant), leading to t-statistics used to test the hypotheses of no association H vt : β vt = 0 with multiplicity adjustment for the pq hypotheses via the Benjamini-Hochberg (BH) procedure at level α (Benjamini and Hochberg 1995) ; and (c) multivariate regression including all possible variables, with subsequent tests on the pq null hypotheses for each coefficient incorporating adjustment via BH procedure at level α. The set of selected variables is equivalent in (a) to the set of estimated nonzero coefficients and in (b) and (c) to the set of variants for which the H vt : β vt = 0 are rejected. We will refer to these approaches as (a) Lasso, (b) BH marginal, and (c) BH full.
The threshold ξ, the penalty of the Lasso, and the level α of BH, can all be considered tuning parameters: we will compare the results of different procedures as these are varied (see details in the supplementary material). We base our comparison on power and realized False Discovery Proportion. The Bayesian methods also provide an estimate of FDR: if Z vt is approximately the probability that variant v is causal for trait t, then the mean of (1 − Z vt ) over the selected variants is the Bayesian False Discovery Rate. We let BFDR denote this mean and explore how well it approximates (or not) the realized FDP, evaluated across all traits and variants.
Genotype and phenotype data
Our work has been partially motivated by a resequencing study in which we participated: Service et al. (2014) analyzed targeted exome resequencing data for 17 regions in subjects of Finnish descent (from the 1966 Northern Finland Birth Cohort (NFBC) and the Finland-United States Investigation of NIDDM Genetics study (FUSION)). While the original study considered six quantitative metabolic traits, we focus here on the fasting levels of High Density Lipoprotein (HDL), Low Density Lipoprotein (LDL), and triglycerides (TG), transformed and adjusted for confounders as in the initial analyses (see supplementary material). The genotype data was obtained by sequencing the coding regions of 78 genes from 17 loci that had been found by previous GWAS meta-analyses to have a significant association to one of the six traits. In addition, we had access to the first five principal components of genome-wide genotypes. The goal of the study is to identify which variants in these hit regions are most likely to directly influence the observed variability in the three distinct lipid traits.
Data cleansing and filtering are described in detail in the supplement; here we limit ourselves to note that before any of the analysis described in this work the collection of variants was pruned to eliminate 550 variants observed only once and to obtain a set of variables with maximal pairwise correlation equal to 0.3 by removing another 558 variants. We decided to drop singletons from consideration since it would not be possible to make inference on their effect without strong assumptions. Two considerations motivated our choice of selecting a subset with only modest correlations: (a) correlated variables make the convergence of MCMC problematic, which might impair our ability to understand the inference derived from the posterior distribution; and, more importantly, (b) it is very difficult to evaluate and compare the performance of model selection methods in the presence of a high correlation between variables. Let us expand on this point: multivariate procedures such as the Lasso would select one out of multiple highly correlated variables that have some explanatory power for the response, approaches such as BH marginal would instead tend to select them all, and Bayesian posterior probabilities for each of the variables would reflect the fact that substitutes are available. It becomes difficult to meaningfully compare FDR and power across these methods, substantially reflecting the fact that the problem is somewhat ill-posed: if multiple highly correlated variables are available, any of them can stand for the others, and it is arbitrary to decide on purely statistical grounds that one belongs to the model while the other does not. Since our goal here is to understand the operating characteristics of the procedures, we found it useful to analyze them in a context where the target is well identified.
After the described pruning, the genetic data used in this paper contains 5335 subjects and 768 variants. Genotypes were coded with minor allele counts, and missing values were imputed using variant average counts. Observed minor allele frequencies range from 2 × 10 −4 to 0.5, with a median of 0.0009 and a mean of 0.02. There are 628 variants with MAF<0.01. Annotation information was obtained as in Service et al. (2014) , resulting in 61% coding, 34% UTR, and the remainder intragenic. Prior to subsequent analysis, the five genetic principal components along with the intercept were regressed out of both X and Y, and the columns of both were then standardized.
Simulation scenarios
We constructed two simulation scenarios: one to simply illustrate the advantages of the proposed priors and the other to investigate their potential in a set-up that models a real genetic investigation.
Illustrative example: orthogonal X
We set n = 5000, p = 50, q = 5, and
In generating β and the responses, we want to cover a range of different signal-to-noise ratios. To achieve this, we sample values of the parameters using the distributional assumptions that we described in the specification of the priors. To explore the performance of the Across Traits and Across Sites models both when they provide an accurate description of reality as well as when they do not, we use three rules to generate the probability with which each variant is associated to each trait: (a) we sample one sparsity parameter ω for each trait and keep it constant across variants; (b) we sample a probability ν v for each variant and keep it constant across traits; and (c) we define groups of five variants and sample one probability ν g of causality for each group of variants and each trait. Rules (a)-(c) are more closely reflected in the prior structure of the basic, Across Traits and Across Sites models, respectively; and we indicate them as exchangeable variants, pleiotropy, and gene effect. We generate 100 datasets per rule, each with q responses, and analyze them with the described set of approaches. When using Bayesian methods, we rely on non-informative priors (see supplement for details).
Actual genotypes X
To explore the potential power and FDR in the analysis of the dataset with three lipid traits, we generate artificial phenotypes starting from the available pruned genotypes. We consider a mixture of possible genetic architectures. In the construction of each dataset, (a) one gene is selected uniformly at random for each phenotype and 3-4 of its rare variants are causal (gene effect); (b) 40 distinct common variants are selected uniformly at random and have probability equal to 0.1 to be causal for each of the phenotypes (they substantially represent trait-specific variants); and, finally, (c) 10 additional common variants are selected uniformly at random and have a probability 0.9 to be causal for each phenotype (pleiotropic effects). This results in traits that are on average determined by 3-4 rare variants in one gene, 4 common variants with effects on one trait only, and 9 common variants with effects across multiple traits. We generated a total of 100 such datasets, as detailed in the supplementary material.
Results
Simulations Illustrative example
The plots on the top row of Figure 3 compare the empirical FDR and power of the different variable selection methods on the dataset with orthogonal X. Points along the curves are obtained by varying tuning parameters and averaging the resulting FDP and power across 100 simulated datasets. Our setting is such that BH full, BH marginal, Lasso and the basic Bayes model have very similar behaviors; the Across Traits and Unadjusted models achieve the highest power per FDR in the presence of pleiotropy and the worst power per FDR in the presence of gene effects; in contrast, the Across Sites model has maximal power in the presence of gene effects and worse power in the presence of pleiotropy. While it is not surprising that the most effective prior is the one that matches more closely the structural characteristics of the data, it is of note that the loss of power deriving from an incorrect choice of the Across Traits or the Across Sites model is minimal for FDR values lower than 0.2, which are arguably the range scientists might consider acceptable (see supplementary information for a detail of these values). On the bottom row of Figure 3 , we compare the estimated BFDR with actual FDR for the Bayesian models; here the most serious mistake is in underestimating FDR, which would lead to an anti-conservative model selection. Once again it can be seen that the best performance is obtained with the prior that matches the data-generating process. Besides this, it is useful to analyze the behavior of the Unadjusted approach: its power increase per FDR in the presence of pleiotropy is less pronounced than that of the Across Traits model, substantially because the Unadjusted approach is too liberal, with a BFDR which is significantly underestimated. This is in agreement with the lack of adjustment for multiplicity noted in section 2.2. Results for alternate hyperparameters are in the supplement. Figure 4 shows the performance of the variable selection methods in the analysis of traits generated from actual genotype data. In the analysis with the Across Sites model, all nonsynonymous rare variants in the same gene are part of the same group, and all remaining variants belong to groups with only one member (see supplementary materials for details). For given FDR, both the Across Traits and Across Sites priors lead to an increase in power over the other methods: this is due to the fact that phenotypes are generated assuming both pleiotropy and gene effects. In the lower portion of Figure 4 , we separate the power to recover trait-specific common variants from that for variants with pleiotropic effects and gene effects: as expected the gains of Across Traits and Across Sites are for the portion of genetic architecture that is accurately reflected in these priors. The estimates BFDR are accurate, indicating that all three Bayesian priors correctly learned τ and the probabilities of function. Finally, while we have relied on ROC-like curves to compare different approaches as the value of their tuning parameters vary, it is useful to focus on the operating characteristics of standard ways of selecting the tuning parameters. By convention, the target FDR for BH is usually 0.05. For Lasso selection, the function cv.glmnet provides two choices for λ: minimizing the cross-validation error and using the one-standard error rule. In Bayesian approaches, one can 
Generating phenotypes from actual genotype data
Across Traits Across Sites
Figure 4: In the top portion, power and BFDR as a function of empirical FDR in the simulation from actual genotype data. In the lower panels, power is calculated separately for the different types of variants: rare, common with trait-specific effects, and common with pleiotropic effects. 
Case Study: the influence of 17 genomic regions on lipid traits
We now turn to the analysis of the three lipid traits in the Finnish dataset. While resequencing data comes from 17 regions identified via GWAS, prior evidence of association is available only between some of these loci and some traits. In particular, four regions have no documented association with any of the three lipid traits we study; we include variants from these loci in the analysis as negative controls. (This is different from the work in Service et al. (2014) , which examines only variants in regions specifically associated with each trait.) Service et al. (2014) relied on univariate regression to test the association between each trait and each variant with MAF>0.01 and on burden tests to evaluate the role of nonsynonymous rare variants. Bogdan et al. (2014) re-analyzed the data relative to HDL with a set of model selection approaches; to facilitate comparison with their results, we add SLOPE to the analysis methods considered so far. Groups for the Across Sites model were defined so as to mimic the burden tests in Service et al. (2014) , containing nonsynonymous variants with MAF<0.01 and in the same gene.
To help the choice of tuning parameters, Table 2 compares the number of variables selected by various methods. The column labeled V * shows the number of selected variants that are in a locus lacking any prior evidence of association to lipid traits. The Lasso with λ chosen to minimize cross-validated prediction error clearly results in far too many selections, so we discard this possibility. For Bayesian approaches, the threshold ξ = 0.7 results in average BFDR approximately controlled at the 0.05 level. Figure 5 illustrates the model selection results for HDL. (Analogous displays for the other two phenotypes are available in the supplementary material, as well as a table detailing differences between approaches.) Each display corresponds to a region, with turquoise shading (rather than orange) used to indicate prior evidence of association to HDL. Variants are arranged according to their genomic positions in the regions, and the values of their estimated coefficients are plotted on the y-axis; with the exception of marginal BH, we display only nonzero coefficients. When available, a vertical black line indicates the position of the SNPs originally used to select the region ('Array SNP'). Table 2 : The columns labeled R and V * give, respectively, the number of variants selected across the entire study and in the four regions with no prior evidence of association to any of the lipid traits analyzed (CRY2, G6PC2, MTNR1B, and PANK1). BFDR reports, for Bayesian methods, the Bayesian FDR.
There is substantial overlap among the results of various methods. Model selection approaches seem to generally agree with the findings in Service et al. (2014) (with Lasso 1-se the most discrepant, missing a number of the associations identified in Service et al. (2014) ; see supplementary material). Still, we can point to some significant differences. With the Across Traits approach we select two variants in two regions where no other method identifies any signal: in CELSR2 and FADS1. These two loci have prior evidence of association to LDL and to the three lipid traits, respectively, and the Across Traits approach identifies pleiotropic effects. In contrast, the Across Traits approach does not select four very rare (MAF<0.001) variants considered relevant by more than one alternative method. While we do not know where the truth lies at this point, it is very hard to evaluate the effect of a rare variant on purely statistical grounds, and the outcome of the Across Traits model might well be the more reliable.
The Across Sites approach identifies five variants that other approaches overlook. Three are rare variants in ABCA1: two missense rare (0.01>MAF>0.001) and one nonsense very rare (MAF 0.00016); their discovery is facilitated by the fact that they are included in a group with multiple other significant variants. The fourth is a common variant in the MVK region, for which there is prior evidence of association to HDL. Other approaches do not recover this simply because the signal in the region is, in the dataset analyzed here, barely below the detection threshold; Across Sites has a slight advantage over the other Bayesian methods because grouping reduces the number of comparisons to account for. The last variant identified only by the Across Sites prior is rare but in an UTR in ABCG8, which has no prior evidence of association to HDL. It has Z v = 0.7002 for this prior but 0.6890 for the basic prior, so it is just on the threshold of selection by both methods.
This dataset consists substantially of coding and URT variants (95% of the total), so annotation information is of limited use in prioritization. In contrast, by analyzing the information through the lens of the different hierarchical prior models, we are able to gain insight on the role of the different variants and the type of effect with which they might be associated.
Discussion
As the genetics community devotes increasing effort to follow up GWAS hits with resequencing, a number of suggestions on how to prioritize variants have emerged. In truth, while dealing with the same broad scientific goals, many of these contributions address different aspects of the problem and therefore should be seen as complementary rather than alternatives: taken together they provide scientists with useful suggestions. Annotation information has been shown to be quite useful when the set of variants under consideration are sufficiently diverse. It is important to account for the correlation across variants to avoid paying attention to SNPs that are only 'guilty by association.' Bayes's theorem and Bayesian statistics are a natural way of dealing with the decision of which variants to follow up. In this context, others have studied (a) how to choose priors that incorporate annotation information, tuning their parameters with available datasets; (b) how to approximate posterior distribution of variant effects; (c) how to sample from the posterior distribution using efficient MCMC or variational schemes; and (d) how to efficiently evaluate posterior probabilities for a set of variants. Here we focus on another aspect of prior selection: describing how partial exchangeability assumptions can be used to borrow information across traits and sites, while maintaining an effective control for multiplicity across variants and fitting multivariate regression models that separate the specific contribution of each associated site. We briefly refer to some of the most direct antecedents of our proposed priors to underscore relevant differences. Yi et al. (2011) proposed the use of hierarchical priors to capture effects of rare variants through groups, similar to the Across Sites model. However, their proposal does not incorporate sparsity considerations, resulting in the estimate of a nonzero effect for each variant and each group and therefore not engaging in model selection.
The Across Sites prior also echoes the proposal of Zhou et al. (2010) who suggested the use of group penalization in Lasso to estimate multivariate sparse models while encouraging coordinated selection of rare variants in the same gene. This computationally appealing approach has not become as popular in genetics as in many other fields, possibly because of the difficulties connected with the selection of its tuning parameters when model selection is the goal. Cross validation is often used to determine the appropriate level of penalization; while this works well for prediction purposes, its performance is less than satisfactory in identifying variables with truly nonzero coefficients (as illustrated by our case study). Alexander and Lange (2011), Valdar et al. (2012) , and, most recently, Sabourin et al. (2015) explore coupling resampling techniques with Lasso penalization to improve model selection. This not only increases computational costs but also greatly reduces the initial simplicity of the model. As documented in Bogdan et al. (2014) , identifying a single λ value that performs FDR control is challenging; Yi et al. (2015) investigates this task in the context of GWAS and provides guidelines. The final model selection of these machine learning approaches derives from complex rules; in contrast, the Bayesian models we described are based on easy to interpret parameters.
The use of hierarchical Bayesian methods has ample precedents in eQTL studies, where they have been used to correct for multiplicity (Kendziorski et al. 2006) and to increase power of detecting variants affecting multiple traits. In our presentation of the Unadjusted and Across Traits approaches, we referred to methods proposed by Jia and Xu (2007) and Bottolo et al. (2011) . More recent work (Flutre et al. 2013; Li et al. 2013 ) has focused on the identification of local (cis) effects across tissues, and considered models with only one functional variant. The recent contribution by Chung et al. (2014) -which appeared while this work was in preparation-underscores as we do the importance of learning both across sites and across traits to prioritize variants. These authors, however, work with p-values from GWAS studies, rather than actual resequencing data.
Having clarified the scope of our contribution, we want to briefly mention how it could be extended and combined with suggestions by others. First, let us point out that while in the simulations and in the analytical approximations we assumed n > p, this restriction is by no means necessary to the Bayesian model we describe. On the contrary, the priors we propose-by learning sparsity and giving positive probabilities to configurations with some β v = 0-are quite adapted to the case n < p. The real challenge in dealing with GWAS-type data would be from a computational standpoint: increased mixing for MCMC as described in Xu et al. (2014) and Guan and Stephens (2011) or other algorithmic improvements (Carbonetto and Stephens 2012; ) would make our approach more widely applicable.
Another extension that is quite easily achieved is the combination of the Across Traits and Across Sites priors. Most immediately, the group indicators G in Figure 2 can be made traitspecific and linked across phenotypes with the same approach used to link the Z t in Figure  1 .
It is quite possible to combine the partial exchangeability aspects of our models with a prior that incorporates annotation information. Refer, for example, to the Across Traits prior in Figure 1 . Currently, the distribution on W 1 , . . . , W p , indicators of functionality of the variants, is a beta-binomial. However, it is quite easy to change it to a mixture of independent logits, with the linear model component including an intercept effect-which would capture the overall sparsity-and a linear combination of annotation indicators (Veyrieras et al. 2008; Kichaev et al. 2014; Pickrell 2014) .
Since our focus has been on specification of the prior, we have not paid much attention to the data-generating model, which could certainly be improved. Specifically, we want to underscore the fact that using a mixed-model approach might be advisable to account for population structure (Kang et al. 2010) and when analyzing many phenotypes whose quantitative value might be influenced by confounders (Zhou and Stephens 2014) .
In conclusion, we want to emphasize the increasing importance in human genetics of models that account for pleiotropy. 'Big data' in genetics has often been equated with the abundance of sequences, and these certainly pose a number of management and interpretation challenges. Our increased acquisition capacity will also result, however, in the collection of a large number of phenotypes; gene expression, MRI scans, and mass spectrometry are just some examples of the large-scale phenotyping efforts underway. Now that DNA variation has been described quite extensively, annotating this appears as a fundamental challenge: the rich phenotypic collections increasingly available have a major role to play. After all, what better way of establishing if a variant has some functional impact than looking for its association with any trait available? Bayesian models that allow one to estimate the probability with which a variant has functional effects across phenotypes are likely to be very useful. In this paper, we have described a first step in this direction.
Supplementary Material Priors for variable selection
To derive the posterior distribution of the basic model, begin with the joint posterior distribution Pr(Z, β, ρ, ω, τ|y) ∝ Pr(y|Z, β, ρ)Pr (β|Z, ρ, τ 
)Pr(ρ)Pr(Z|ω)Pr(ω)Pr(τ). (4)
Using the popular choice of conjugate priors for ω and Z allows us to integrate out ω to obtain
which means |Z| has a beta-binomial distribution.
Integrating out β uses the following result:
This implies
, since the integrand is the density function, up to a normalizing factor, of N Ω Z X T Z y, 1 ρ Ω Z . Next multiply this by the prior density function for ρ and integrate to obtain
since the integrand is the density function of Gamma α ρ + n 2 , λ ρ + 1 2 S 2 Z , up to a normalizing factor. Hence, the marginal posterior for Z and τ is given by
With the g-prior, the last factor simplifies to (1 + nτ 2 ) −|Z|/2 and S 2 Z = y T y − nτ 2 1+nτ 2 SS Z , where SS Z denotes the sum of squares from the ordinary least squares solution for X Z . Hence, when |Z| = 0, we use S 2 Z = y T y and the last factor in (9) is one. We also use these values when |Z| = 0 even when not using the g-prior. Probably the best argument for this is that the two values of Σ Z are essentially equal when |Z| = 1, so it seems reasonable to make them equal when |Z| = 0.
The approximation of E[Z v |Z [−v] , τ, y] depends upon some assumptions about the hyperparameters, which we now motivate. At the same time, we also state the hyperparameters in most our computations; the effect of alternate hyperparameters is discussed below. For fine-mapping, there is considerable uncertainty about the likely value of ω, so we used the uninformative prior with A ω = B ω = 1. We also used these parameters for all the beta distributions in the other priors.
Next we discuss the hyperparameters for ρ. As explained in the text, nτ 2 1 is necessary in order to distinguish signal from noise; and assuming this to be true implies Ω Z ≈ (X T Z X Z ) −1 for either choice of Σ Z , which in turn implies S 2 Z is approximately equal to the residual sum of squares (RSS) for the model indicated by Z. Finally, the portion of variance explained (PVE) by the model is typically small for genetic association, so RSS is not much less than y T y ≈ n for any model. Hence, choosing α ρ = λ ρ n 2 means that these parameters have very little effect on the marginal posterior (9). We use α ρ = λ ρ = 10 in our analyses, which have n ≥ 5000.
Finally, we consider the bounds on the uniform prior for τ. The lower bound could be zero, but this may lead to increased computational times because very small τ implies small nonzero values in β are more likely, which may make the MCMC iteration accept larger models. The assumption nτ 2 1 suggests choosing 
. (10) We will simplify the expression on the left and then solve for E[Z v |Z [−v] , τ, y]. Assuming α ρ and λ ρ are negligible in the marginal posterior gives
Properties of the beta and gamma functions give
For orthogonal X, the two choices of Σ Z are essentially the same. If nτ 2 1 as well, det(
because the PVE is small. Substituting these results into (10) gives
Learning across traits
While the Unadjusted prior is not useful, we include its marginal posterior density here for completeness. Its derivation is very similar to that of the basic model, so we focus on the differences. A priori the rows of Z are independent and each has a beta-binomial distribution similar to (5), so
Furthermore, the columns of Y are independent given Z, β, and ρ, and similarly for the columns of β; so
If Z andZ are equal except that Z vt = 0 andZ vt = 1 for one v and one t, then the same calculations as for the basic model give that (11) simplifies as
This leads to the approximation
Now we consider the Across Traits prior. Incorporating W has no effect on most of the factors in (4), so the posterior density is the same as in (16) except that f Z is replaced by
To derive the approximation for the posterior expected values, consider W andW that are equal except that W v = 0 andW v = 1 for one v. Also choose Z consistent with W, which means f W,Z (W, Z) = 0. Straightforward modification of (10) gives
where the summation is over allZ such thatZ [−v] = Z [−v] . Furthermore, for any suchZ,
where the summation is over all 2 q possible values of Z v .
Learning across sites
The derivation of the marginal posterior for learning Across Sites consists of straightforward modifications of previous calculations. The marginal posterior distribution is as in (9) except that the prior f Z (Z) is replaced by the joint prior for Z and G, which is
with the summation being over all 2 p g possible values of Z g . When p g = 1, however, the summation is replaced by (1
, where v is the lone variant in group g.
MCMC sampling
To define the notation, the Metropolis-Hastings algorithm to generate samples with density proportional to f (·) draws a proposalũ from a jumping distribution Q(ũ|u (m) ), where u (m) is the previous sample. Next, compute
The new sample isũ with probability min(R, 1) and is u (m) otherwise. To avoid overflow, we actually compute ln R and then take its exponential. The remainder of this section gives the definition of the jumping distributions used. The jumping distribution forτ given τ is N (τ, (τ 2 − τ 1 ) 2 /16) but truncated to the interval (τ 1 , τ 2 ). Regardless of how the marginal posterior is defined for an empty model, r = 1 for any two values of τ that are in (τ 1 , τ 2 ) when |Z| = 0. Hence, if all effect sizes are very small, the τ samples may be essentially uniform. This is because the data do not enable learning the effect sizes and has nothing to do with the MCMC algorithm or its convergence.
With one level of indicator variables, our proposal distribution Q(Z|Z) is nonzero only if Z − Z = δe v for some v and δ ∈ {−1, +1}, where e v is the vector with entry v equal to one and all others equal to zero. Furthermore, for such Z andZ,
where π + is the probability of adding a variable to the model. Next we define Q W,Z (W,Z|W, Z) for learning Across Traits. The first step at each iteration is to choose δ from {−1, 0, +1} with probabilities π * − , π * 0 , and π * + , respectively, with obvious modifications if, say, δ = −1 is not possible because |W| = 0. ThenW − W = δe v , where variant v is chosen uniformly from the possible candidates. The proposalZ will be the same as Z except for changes to
with q replacing p. If δ = +1, then drawZ v based on the prior for (Z|W): first draw s v from the beta-binomial distribution
and then sample s v distinct entries uniformly from {1, . . . , q}. The overall jumping probability is
and the nonzero values of the mass function for (W|W) are
The value ofπ W is irrelevant because it will be the same for Q W (W|W) and Q W (W|W), which will consequently cancel each other in (25). Furthermore, if δ = +1, then Q 0 (Z|W, W, Z) in the denominator in (25) will cancel the leftover factor in f W,Z (W,Z) in the numerator; whereas for δ = −1 a factor in f W,Z (W, Z) cancels Q 0 (Z|W,W,Z). The mass functions for the Across Sites prior are more complicated, but the fortunate cancellations still occur. First, p g replaces p in (26) to give Q * Z (Z g |Z g ) when δ = 0, and (28) becomes
Let G * g = 1 if G g = 1 and p g > 1; otherwise it is zero. Assuming that at least one group has p g > 1, the nonzero values of the mass function for (G|G) are 
In our experiments, π + = 0.5 for the Z proposal, while π * 0 = 0.5 and π * − = π * + = 0.25 for the W or G proposal. One chain starts with no variants in the model, another starts with all variants in the model. For the other two chains, the variants are ranked by the absolute value of their correlation with y t , and the J t most strongly correlated have Z vt set to one. For the actual phenotypic data, J t is 10 for one chain and 20 for the other. For the simulations, one chain has J t equal to the expected number of variants that are causal for trait t (as determined by the ω or ν used to generate Z t ), and the other chain has J t double that. The burn-in interval was 10,000 iterations. For the simulated datasets, 500,000 samples were then used to compute the averages, which took a few hours running the chains sequentially. For the actual data, 10 times as many samples were used for the averages; the chains were run in parallel and the run times were again a few hours. We always used the g-prior.
To assess convergence of the averages Z vt , we computed the average for each chain and then set ∆Z vt equal to the difference between the maximum and minimum averages over the four chains. For each prior applied to each set of 100 datasets, at least 95% of ∆Z vt were less than 0.05. For the priors that incorporate W or G, at least 95% of the analogous values of ∆W v or ∆G g were less than 0.05 except that only 92% of ∆G g satisfied this condition when the Across Sites prior was applied to the traits simulated from the genotype data. Empirically, ∆Z decreases as O(M −1/2 ), where M is the number of iterations.
Evaluation of variable selection performance
The p-values for use in the BH procedure are from ordinary least squares, using either one variant at a time ('marginal') or all variants simultaneously ('full'). For each dataset, we apply BH to all traits simultaneously, which means each BH test has pq hypotheses. For the performance curves, we choose a target FDR, say α, and apply BH with that α to each dataset, computing the false discovery proportion (FDP) and of discoveries of true null hypotheses for each dataset. We then average over the 100 datasets to obtain the FDR and power for one point in our plots. For our performance curves, we used the FDR control targets {0. 001, 0.005, 0.01, 0.05, 0.1, 0.3, 0.5} . Applying BH to the traits separately gave essentially the same results for the simulated data; the effect of testing phenotypes separately in the actual data is discussed below.
The performance curves for the Lasso show the effect of varying the penalty parameter λ. We use the R function glmnet with its default parameters (with family='gaussian') except without an intercept. This returns the fits for a set of λ values, but that set depends upon the input data. We compute the FDP and power at each value of λ output for that trait. Using locpoly() in the R package KernSmooth, we perform local linear regression on all these points for all datasets to approximate FDP and power as functions of λ. When instead choosing a specific λ by cross-validation, the one-standard error rule gives the largest value of λ such that the cross-validation error is within one standard error of the minimum error. In this case, the choice depends upon the randomly drawn cross-validation bins, so for reproducibility we set the random seed to 1234 immediately before calling cv.glmnet.
To compute the performance curves for Bayesian selection of variants, we choose threshold ξ, select using the rule Z vt > ξ for each dataset, compute the FDP and power for each dataset (same as for BH), and then average over all 100 datasets to obtain one point in our plots. The values of ξ were 0.01 , 1 − 0.01 , and 0.1 for = 1, . . . , 9.
Genotype and phenotype data
Starting with the genotype and phenotype data in Service et al. (2014) , we removed 786 individuals that were missing values for any of the principal components or the three traits HDL, LDL, and log-transformed TG, leaving 5335 subjects. From the sequencing data that had passed quality control, we removed two variants that were missing data for over 20% of the subjects as well as variants whose minor allele occurred only once in the remaining subjects, leaving 1326 variants.
Additional filtering involved: (1) annotation, whose possible values were nonsense, missense, coding synonymous, UTR 5 , UTR 3 , intron, and unknown; (2) PolyPhen2 predictions, whose possible values were probably damaging, possibly damaging, benign, and unknown; (3) marginal regression p-values from Service et al. (2014) ; and (4) minor allele frequency (MAF). If all subjects have exactly the same genotype (including missing values) for two or more variants, we chose one of the variants using the ad hoc rules in Figure 6 , thereby eliminating 24 more variants. Figure 7 gives an algorithm to choose from correlated variants. To simplify comparison with Service et al. (2014) and Bogdan et al. (2014) , we only dropped variants mentioned in those papers when they were correlated with each other.
Variants in dbSNP version 137 are indicated with their rs names, while other variants are referred to as v_c9_107548661, say, specifying chromosome and position (from GRCh37). Service et al. (2014) list 39 associations between an 'Array SNP' and a trait. Of those, 16 had p-value less than 0.001 for their data and involved one of the three traits HDL, LDL or TG. Our filtering process dropped one of these: rs10096633, which was an Array SNP for both HDL and TG, because it had correlation 0.96 with rs328, which has a nonsense mutation. Among the new discoveries reported by Service et al. (2014) , rs651821 and rs2266788 in gene APOA5 are both associated with one of our traits, but we had to drop one of them because their correlation is 0.95. We dropped the latter because it had a slightly stronger correlation with the Array SNP rs12805061. After filtering, we put rs12805061 and rs3135506 (which is a missense mutation predicted to be probably damaging) back into X, which then had 768 variants. After imputation, X had all pairwise correlations less than 0.3 except for two that were slightly greater.
Using the phenotype data (via the p-values) when filtering the variants could affect the accuracy of methods to estimate or control FDR, but our previous experience has been that this does not occur in this situation.
Simulation scenarios
For the datasets with orthogonal X, we set n = 5000, p = 50, q = 5, and X = n−1 n/p (I p I p · · · I p ) T so that X T X = (n − 1)I p . The columns of X were not centered because that would destroy the orthogonality. In generating phenotypic data, ρ = 1, τ ∼ Unif(0.045, 0.063), nonzero β vt ∼ N (0, τ 2 ), and the distributions of the probabilities of association were as follows:
For each of the 23 sets of variants for which all subjects have the same genotype If they are on the same chromosome and have the same annotation and PolyPhen2 prediction Choose one arbitrarily Else if exactly one variant has annotation 'missense' (none had 'nonsense') Choose it Else if no variant has annotation 'missense' Choose the one with annotation 'coding synonymous' (which meant discarding UTR 3 variant or variant without annotation) Else (this case only occurred once)
Choose the one with PolyPhen2 prediction of 'probably damaging' (which meant discarding the variant predicted to be benign) Figure 6 : Pseudocode for eliminating duplicate variants. C is the absolute value of the correlation matrix of V, computed with R option use="pairwise.complete.obs" Consider the entries of C ij in decreasing order
If v i and v j are on different chromosomes, continue Add to V * all v on same chromosome as v i and such that C i or C j is greater than c 0 U 0 contains any entries in V * that we particularly want to keep (see text) U 1 = argmin v i ∈V * p-value-but only consider common variants U 2 contains variants in V * with the 'worst' annotation, where the ordering is nonsense, then missense with probably damaging, then missense with possibly damaging, then missense with any prediction If U 0 is not empty U is the entry in U 0 with the highest priority Else if U 1 is empty
Stop in the following rules when one gives single variant u:
1. u ∈ U 2. u is variant in U with greatest MAF 3. Choose u from U arbitrarily Drop u from V and C 
so the generated traits also had variance close to one-between 0.94 and 1.17. There were 100 datasets, each with q = 5 traits. When applying the Across Sites prior to any of these data sets, the groups are the same as when generating the dataset with gene effect: the first group consists of the first five variants, the second group consists of the next five variants, and so forth. When simulating phenotypes from the actual genotype data, all rare (MAF<0.01) variants in the same gene with missense or nonsense mutations are in the same group. Every other variant-common or rare-is in a group by itself. Then Z was generated randomly as follows:
• for each trait t, draw one group from amongst those with at least five variants and set Z vt = 1 for 3-4 rare variants (number drawn uniformly) in that group
• draw 10 common variants and, for every trait t, set Z vt = 1 with probability 0.9
• draw 40 common variants and, for every trait t, set Z vt = 1 with probability 0.1
The rest of the process to generate each trait was the same as in the other simulations. Again, there were 100 datasets, each with q = 3 traits. There are 20 genes with at least five nonsynonymous rare variants; 16 of them have fewer than 10 variants, but the others have 14-16 variants.
Results for illustrative example
For our Bayesian variable selection methods and several non-Bayesian methods applied to the datasets with orthogonal X, Figure 8 compares the power for FDR less than 0.2. In this range, the power of the Across Sites prior applied to the dataset with pleiotropy is only slightly less than that of the basic prior or the non-Bayesian methods. Similarly, the loss of power of the Across Traits prior applied to the dataset exhibiting gene effects is slight when FDR is less than 0.2.
We also investigated the effect of using other hyperparameters. Figure 9 shows the results when the prior for τ was Unif(2, 5) but everything else was the same as for the results in Figure 8 . As suggested by the approximations (14) and (18), increasing τ causes Z vt to decrease; so fewer variables are selected for given ξ, decreasing both FDR and power. This also means that Z vt underestimates the probability that variant v is causal for trait t, and BFDR greatly overestimates FDR. On the other hand, using the prior τ ∼ Unif(0.045, 0.063) as was used in data generation gave essentially the same results as in Figure 8 because the mean and variance of the τ samples were usually less than 0.1 when using the uninformative prior τ ∼ Unif(0.01, 10).
Finally, we tried using different hyperparameters for the priors on the probabilities of causality but with everything else the same as for the results in Figure 8 . For the dataset with exchangeable variants, we again used uninformative priors for ω W and ω G but all other Beta priors had parameters A = 12 and B = 48. For the dataset with pleiotropy, we changed only the hyperparameters for ν for the Across Traits prior, which now have the same values as during data generation, and likewise for the dataset with gene effects and the Across Sites prior. Figure 10 shows that this did not have much effect on the results. This suggests there is not much advantage to using tighter priors, even if it were possible to guess the hyperparameters so accurately.
Results for generating phenotypes from actual genotype data
When applying the Across Sites prior to data with actual genotype data, the groups were the same as described above for simulating phenotypes from this data. This mimicked the burden tests in Service et al. (2014) .
To create the performance curves for the different variant effects on the phenotypes simulated from actual genotype data, the FDR for each ξ is equal to that computed for the curves for all variants, but the power is computed separately for each type of variant effect. For the actual data, BFDR is computed separately for each trait. Table 3 shows the FDR and power when using specified values of ξ to select variants or groups from applying the Bayesian models to the simulations with actual genotype data. The results when ξ = 0.7 are essentially the same as the results in the paper from controlling BFDR ≤ 0.05.
Results for the case study
Figures 11 and 12 illustrate the model selection results for LDL and TG, respectively, which are interpreted in the same way as the figure for HDL in the main paper. Tables 4-6 list the methods that select each variant for association with HDL, LDL, and TG, respectively, for variants selected by at least one method. An x in a column indicates that the method selects that variant for that trait. The column labeled 'position' gives the position (from GRCh37) of the variant on its chromosome.
No method identifies any rare variant for either LDL or TG, and the Across Sites approach is in the majority with all its selections. The Across Traits approach selects a few variants that are noteworthy. For LDL, it selects a variant in each of three regions-CETP, GALNT2, and NCANwhere no other method identifies any signal. In each case, the variant that the Across Traits approach selects has a strong association with either HDL or TG. Two of these three regions have previous evidence of association with LDL. For TG, the Across Traits approach selects a variant in FADS1, where no other method selects any. This is the same variant that caught our attention when only the Across Traits approach selected it for HDL. Again, this locus has previous evidence of association with TG.
To conclude, we note that applying BH to each phenotype separately gives different results in some cases. When applied to the p-values from the full model for HDL only, BH selects four variants that it does not select when applied to all traits simultaneously: rs2066715 in ABCA1, rs651821 in APOA1, rs34216426 in CETP, and rs611229 in GALNT2. All of these are also selected for HDL by most other methods. When applied to marginal p-values for HDL only, BH selects three variants that it does not select when applied to all traits simultaneously: variant position locus MAF rs62136410 44022092 ABCG8 0.0533 rs2303790 57017292 CETP 0.0006 rs11988 47261260 MADD 0.3005
Most methods select rs2303790 for HDL, but no other methods select the other two of these; and ABCG8 does not even have prior evidence of association to HDL. The final difference arising from applying BH to traits separately is that it does not select rs145756111 in ABCG8 for association with LDL when using marginal p-values, which brings it into agreement with the other methods on this variant.
